Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

Finlay Minerals Ltd. TSX-Venture Symbol: FYL All Issues: Yes Resumption (ET): 1:30 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets from ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

US - Hikma And Amici Curiae Ask Supreme Court To Revisit Induced Infringement by Generic “Skinny Labels”. Legal News and ...

Given the large stake in the stock by institutions, Hikma Pharmaceuticals' stock price might be vulnerable to their trading decisions. A total of 12 investors have a ...

Hikma Pharmaceuticals PLC announced the granting of discretionary share awards under its 2023 Long Term Incentive Plan (LTIP) and Deferred Bonus Plan (DBP) to key managerial personnel. These awards, ...

Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key ...

Rucaparib has received regulatory approval from the European Medicines Agency (EMA) and the United States Food and Drug ...

Jefferies raises Hikma Pharmaceutical to 'buy' (hold) - price target 2,400 (2,090) pence Jefferies cuts Peterhill Partners price target to 250 (280) pence - 'buy' ...

A newly released report from Future Market Insights (FMI) reveals a promising decade ahead for the saudi arabia pharmaceutical market, forecasting a significant surge in market growth. With a ...